MondegarAI
Aldebaran Capital, LLC

Q1 2026 · 13F-HR

Aldebaran Capital, LLCholdings as filed

Filed 2026-05-07 · accession 0001376474-26-000360

$130.8M
Reported value
43
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · Aldebaran Capital, LLC · Q1 2026

AI · grounded in 13F

Aldebaran Capital, LLC established a new position in GLNCY valued at $5.09M. The fund also opened new stakes in LKQ for $3.00M and ZD for $1.73M. To offset these additions, the fund reduced its holdings in RELL by 21.02% and SU by 10.26%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
084670702BRK/BBERKSHIRE HATHAWAY INC DEL$19.3M14.7%40,177CommonSOLE
674599105OXYOCCIDENTAL PETE CORP$10.0M7.66%154,152CommonSOLE
H11356104BGBUNGE LIMITED$8.6M6.57%67,612CommonSOLE
532457108LLYLILLY ELI & CO$8.3M6.33%9,007CommonSOLE
594918104MSFTMICROSOFT CORP$7.5M5.76%20,354CommonSOLE
867224107SUSUNCOR ENERGY INC NEW$6.8M5.23%103,481CommonSOLE
464287473IWSISHARES TR RUS MDCP VAL$5.8M4.47%40,125CommonSOLE
166764100CVXCHEVRON CORP NEW$5.5M4.19%26,471CommonSOLE
37827X100GLNCYGLENCORE PLC$5.1M3.89%335,056CommonSOLE
060505104BACBANK AMERICA CORP$5.1M3.88%104,202CommonSOLE
00461U105ACRSACLARIS THERAPEUTICS INC$3.6M2.72%947,162CommonSOLE
003261104BCIABRDN ETFS$3.5M2.66%143,384CommonSOLE
156431108CENXCENTURY ALUM CO$3.4M2.58%57,570CommonSOLE
149205106CATOCATO CORP NEW$3.3M2.55%1,176,687CommonSOLE
46625H100JPMJPMORGAN CHASE & CO$3.3M2.54%11,282CommonSOLE
92343V104VZVERIZON COMMUNICATIONS INC$3.0M2.30%59,863CommonSOLE
501889208LKQLKQ CORP$3.0M2.29%102,098CommonSOLE
35671D857FCXFREEPORT-MCMORAN INC$2.9M2.19%48,773CommonSOLE
03237H101AMLXAMYLYX PHARMACEUTICALS INC$2.8M2.10%197,892CommonSOLE
829933100SIRISIRIUS XM HOLDINGS INC$2.7M2.04%115,403CommonSOLE
29250N105ENBENBRIDGE INC$2.2M1.65%39,879CommonSOLE
48123V102ZDZIFF DAVIS INC$1.7M1.32%41,171CommonSOLE
60855R100MOHMOLINA HEALTHCARE INC$1.7M1.28%12,608CommonSOLE
703343103PATKPATRICK INDS INC$1.5M1.18%13,872CommonSOLE
084670108BRK/ABERKSHIRE HATHAWAY INC DEL$1.4M1.10%2CommonSOLE
373261056AN2 THEREAPEUTICS INC$1.3M0.97%371,770CommonSOLE
878972108TECXTECTONIC THERAPEUTIC INC$1.1M0.88%37,184CommonSOLE
763165107RELLRICHARDSON ELECTRS LTD$1.0M0.79%93,969CommonSOLE
46435U374EWJVISHARES TR MSCI JP VALUE$706,8290.54%16,565CommonSOLE
49372L2092KZ0KEZAR LIFE SCIENCES INC$596,0860.46%80,335CommonSOLE
69353Y103PMVPPMV PHARMACEUTICALS INC$586,9690.45%473,362CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$483,9090.37%89,946CommonSOLE
26441C105DUKDUKE ENERGY CORP NEW$471,3840.36%3,600CommonSOLE
58844R108MBINMERCHANTS BANCORP IND$434,4640.33%10,125CommonSOLE
369604103GEGENERAL ELECTRIC CO$354,9960.27%1,251CommonSOLE
345370860FFORD MTR CO DEL$317,3500.24%27,500CommonSOLE
674599162OXY/WSOCCIDENTAL PETE CORP$306,2200.23%7,138CommonSOLE
36828A101GEVGE VERNOVA INC$289,8030.22%332CommonSOLE
063671101BMOBANK MONTREAL QUE$230,0780.18%1,700CommonSOLE
30231G102XOMEXXON MOBIL CORP$211,2270.16%1,245CommonSOLE
447324104HURCHURCO CO$201,9540.15%13,729CommonSOLE
68277Q105OKURONKURE THERAPEUTICS INC$167,3350.13%40,419CommonSOLE
45175G207IMAIMAGENEBIO INC$92,8300.07%18,566CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.